Salivary concentration of 5-hydroxytryptamine in patients with bulimia nervosa

Biogenic Amines

Volumn 18, Issue 3-6, 2004, Pages 361-368

  Takahashi, N ^a   Hamaue, N ^a   Kuronuma, N ^a   Yoshihara, T ^a   Ando, S ^a   Hirafuji, M ^a   Endo, T ^a   Senjo, M ^b   Parvez, S H ^c   Minami, M ^a  

^a HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^b Goryokai Hospital   (Japan)

^c CNRS   (France)

Author keywords

Avoidant personality disorder; Bulimia nervosa; Eating disorder; Human study; Salivary 5 HT; Salivary DOPAC

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BIOCHEMICAL MARKER; MONOAMINE; SEROTONIN;

ADULT; ARTICLE; AVOIDANT PERSONALITY DISORDER; BEHAVIOR DISORDER; BODY MASS; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MENTAL PATIENT; MOOD DISORDER; SALIVA LEVEL; STATISTICAL ANALYSIS; STRESS; VOLUNTEER;

EID: 4344676832     PISSN: 01688561     EISSN: None     Source Type: Journal    
DOI: 10.1163/1569391041501816     Document Type: Article

References (29)

1. Baumann, O., Dames, P., Kuhnel, D., et al. (2002). Distribution of serotonergic and dopaminergic nerve fibers in the salivary gland complex of the cockroach Periplaneta Americana, BMC Physiol. 2,9.
2. Culley, W. J., Saunders, R. N., Mertz, E. T., et al. (1963). Effect of a tryptophan deficient diet on brain serotonin and plasma tryptophan level, Proc. Soc. Exp. Biol. Med. 113, 645-648.
3. DSM-lV (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, DC, USA.
4. Endo, T., Minami, M., Monma, Y., et al. (1990). Effect of GR38032F on cisplatin- and cyclophosphamide-induced emesis in the ferret, Biogenic Amines 8, 79-86.
5. Erspamer, V. and Testini, A. (1959). Observations of the release and turnover rate of 5-hydroxy-tryptamine in the gastrointestinal tract,J Pharm. Pharmacol. 11, 618-623.
6. Essman, W. B. (1978). Serotonin distribution in tissues and fluids, in: Serotonin in Health and Disease: Vol. 1, Availability, Localization and Distribution, Essman, W. B. (Ed.), pp. 15-180. S.P. Medical and Scientific Books, New York.
7. Frank, G. K., Kaye, W. H., Weltzin, T E., et al. (2001). Altered response to meta-chlorophenyl-piperazine in anorexia nervosa support for a persistent alteration of serotonin activity after short-term weight restoration, Int. J. Eat. Disord. 30, 57-68.
8. Frank, G. K., Kaye, W. H., Meltzer, C. C., et al. (2002). Reduced 5-HT2A receptor binding after recovery from anorexia nervosa, Biol. Psychiatry 52, 896-906.
9. Freed, C. R., Echizen, H. and Bhaskaran, D. (1985). Brain serotonin and blood pressure regulation: studies using in vivo electrochemistry and direct tissue assay, Life Sci. 37, 1783-1793.
10. Kaye, W. H. and Weltzin, T. E. (1991a). Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood, J. Clin. Psychiatry 52 (Suppl.), 41-48.
11. Kaye, W. H. and Weltzin, T. E. (1991b). Neurochemistry of bulimia nervosa, J. Clin. Psychiatry 52 (Suppl.), 21-28.
12. Kaye, W. H., Greeno, C. G., Moss, H., et al. (1998). Alterations in serotonin activity and psychiatric symptoms after recovery from bulimia nervosa, Arch. Gen. Psychiatry 55, 927-935.
13. Korf, J. (1969). The determination of 5-hydroxytryptamine in human urine, Clin. Chim. Acta 23, 483-487.
14. Malmgren, R. and Hasselmark, L. (1988). The platelet and the neuron: two cells in focus in migraine, Cephalalgia 8, 7-24.
15. Marukawa, H., Shimomura, T. and Takahashi, K. (1996). Salivary substance P, 5-hydroxytryptamine, and γ-aminobutyric acid levels in migraine and tension-type headache, Headache 36, 100-104.
16. Matsumoto, M, Togashi, H., Yoshioka, M., et al. (1990). Simultaneous high-performance liquid chromatographic determination of norepinephrine, serotonin, acetylcholine and their metabolites in the cerebrospinal fluid of anesthetized normotensive rats, J. Chromatogr. 526, 1-10.
17. Minami, M., Endo, T., Nemoto, M., et al. (1995). How do toxic emetic stimuli cause 5-HT release in the gut and brain? in: Serotonin and the Scientific Basis of Anti-emetic Therapy, Reynolds, D.J.M., Andrews, P.L.R. and Davis, C.J. (Eds), pp. 68-76. Oxford Clinical Communications, Oxford.
18. Minami, M., Endo, T., Hirafuji, M., et al. (2003). Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity, Pharmacol. Ther. 99, 149-165.
19. Moir, A. T. (1971). Interaction in the cerebral metabolism of the biogenic amines: effect of intravenous infusion of L-tryptophan on the metabolism of dopamine and 5-hydroxyindoles in brain and cerebrospinal fluid, Br. J. Pharmacol. 43, 715-723.
20. Murakawa, H., Shimomura, T. and Takahashi, K. (1996). Salivary substance P, 5-hydroxytryptamine, and g-aminobutyric acid levels in migraine and tension-type headache, Headache 36, 100-104.
21. Ruwe, W. D., Naylor, A. M., Bauce, L., et al. (1985). Determination of the endogenous and evoked release of catecholamines from the hypothalmus and caudate nucleus of the conscious and unrestrained rat, Life Sci. 37, 1749-1756.
22. Shimomura, T. and Takahashi, K. (1990). Alteration of platelet serotonin in patients with chronic tension-type headache during cold pressor test, Headache 30, 581-583.
23. Shintani, F., Kanda, S., Nakaki, T., et al. (1993). Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus, J. Neurosci. 13, 3574-3581.
24. Tyce, G. M., Stockard, J., Sharpless, N. S., et al. (1983). Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa, Clin. Pharmacol. Ther. 34, 390-398.
25. Udenfriend, S. and Weissbach, H. (1958). Turnover of 5-hydroxytryptamine (serotonin) in tissues, Proc. Soc. Exp. Biol. (NY) 97, 748-751.
26. Wallenstein, S., Zucker, C. L. and Fleiss, J. L. (1980). Some statistical methods useful in circulation research, Circ. Res. 47, 1-9.
27. Welch, K. M., Meyer, J;S., Teraura, T., et al. (1972). Ischemic anoxia and cerebral serotonin levels, J. Neurol. Sci. 16, 85-92.
28. Wurtman, R. J. and Wurtman, J. J. (1986). Carbohydrate craving, obesity and brain serotonin, Appetite 7 (Suppl.), 99-103.
29. Yoshioka, M., Kikuchi, A., Matsumoto, M., et al. (1993). Evaluation of 5-hydroxytryptamine concentration in portal vein measured by microdialysis, Res. Commun. Chem. Pathol. Pharmacol. 79,370-376.